Search results for: 'Solutions payment'

The World Health Organization (WHO) made the following statement many years ago, “There is no health without mental health”. Today, as the COVID-19 pandemic ravages the world, another public health crisis is looming over our health systems—that of deteriorating mental health. Mass unemployment, salary reductions, depleting financial security nets, ...

This Frost Radar™ benchmarks the growth and innovation activity of clinical decision support system (CDSS) vendors in their effort to provide end users with evidence to take the next best action. The CDSS role is evolving from just being the source of clinical knowledge at the point of care or facilitating clinical decision-making and workflow. New...

17 Nov 2020  |  North America  |  Market Research

Business Models Focusing on Patient Centricity Driving Incremental Value in the Global Digital Patient Engagement Solutions Market, 2025

Growth Strategies to Revolve Around Value-based Care and Population Health Management Initiatives

Infographics

×

Healthcare is evolving, more so after the Coronavirus 2019 (COVID-19) pandemic that hit us in the beginning of 2020. Over time, we have seen surveys that indicate that patients want more control of their healthcare and be active participants of their treatment decisions. Innovations in technology and recent developments in the healthcare ecosystem ...

Digital health offered extensive support and grew stronger as the pandemic continued with several variants across the globe. Telehealth and other enterprise IT solutions continued to be the backbone for healthcare systems, and access to health in the hands of the patients empowered consumers to manage their health with the best of tools. As the dem...

30 Jan 2020  |  North America  |  Market Research

Assessment of the US Revenue Cycle Management Market, Forecast to 2024

The Next Generation RCM is Prioritizing Consumer Centricity

Infographics

×

This study primarily strives to: • Analyze the market forces affecting the utilization of next-generation Revenue Cycle Management (RCM) IT and service solutions among US hospitals and physician practices. • Evaluate the latest regulatory objectives that mandate episodic financial risk management initiatives. • Highlight the best practi...

01 Jun 2021  |  North America  |  Frost Radar

Frost Radar™: US Population Health Management Market, 2021

A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines

Infographics

×

After pausing while the US healthcare industry struggled to contain COVID-19, the stringent audit process for value-based care (VBC) is back in full swing for 90% of Medicare reimbursement that is currently attributed to some form of quality or risk-based payment plan. Additionally, CMS has launched new guidance for value-based reimbursement among ...

25 Mar 2022  |  North America  |  Frost Radar

Frost Radar™: North American Clinical Documentation Improvement Market, 2022

A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines

Infographics

×

Clinical documentation improvement (CDI), a vital mechanism in documenting care in the healthcare space, is a strategic necessity that goes beyond a component in the broader revenue cycle management (RCM) of claims processing. It focuses on improved patient outcomes, supports data quality that tells an accurate story of the patient’s care, facilita...

This research service provides an overview of the US revenue cycle management, revenue forecast, and competitive analysis of various legacy and modular RCM solutions. This study explores RCM applications across front-end, middle, and back-end processes and the end users are hospitals and ambulatory physician practices. In addition, it offers detail...

Patients with long-term chronic conditions and rare diseases are looking for safe, novel, and evidence-based digital treatments in their pursuit to reduce dosages and reverse triggers of adverse events. Payers and providers are looking for legitimate alternatives to expensive medication for their patient population. Life sciences (LS) companies are...